Connect with us

New York Islanders

Semyon Varlamov Placed in COVID-19 Protocol Following Warmups

Published

on

New York Islanders goaltender Semyon Varlamov

After leading the New York Islanders out for warmups Saturday night prior to their contest against the Calgary Flames, goaltender Semyon Varlamov did not come out of the tunnel with the team for puck drop. Ilya Sorokin was in goal to start the contest.

During the first period, the New York Islanders announced that Semyon Varlamov had been placed into COVID-19 protocol.

26-year old Colin Cooper, who played hockey at Mount Royal University in Calgary, served as the EBUG.

If Semyon Varlamov’s COVID-19 test was a confirmed positive (PCR), he must quarantine for five days in Canada according to Alberta’s regulations. The first day is day zero, which means five days following that before he can leave Canada.

That means Varlamov will not be available for the New York Islanders contest against the Buffalo Sabres (Feb. 15) and Boston Bruins (Feb. 17). He will be available to come out of quarantine on Feb. 18.

With Varlamov unavailable, the New York Islanders will need to call up a netminder from the Bridgeport Islanders. With it just being a two-game absence for Varlamov, Ilya Sorokin will more than likely get both starts.

The NHL and the NHLPA stated that only players who have shown COVID-19 symptoms would need to be tested. But the one caveat to their decision was that players must test before crossing over from the United States into Canada.

Welcome to your new home for New York Islanders breaking news, analysis and opinion. Like us on Facebook, follow us on Twitter and don't forget to subscribe to NYHN+ for all of our members-only content from Christian Arnold and the National Hockey Now network.

GET NYIHN IN YOUR INBOX!

Enter your email address to get all of our articles delivered directly to your inbox.

NYI Team & Cap Info

Recent Comments

Get the best of NYI Hockey Now in your inbox

Sign-up and get all of the best Islanders breaking news and analysis sent straight to your inbox.

Thank you for subscribing.

Something went wrong.